Predictors of Residual Pulmonary Vascular Obstruction after Pulmonary Embolism: results from a prospective cohort study

F. Couturaud (Brest, France), G. Picart (Brest, France), P. Robin (Brest, France), C. Tromeur (Brest, France), R. Le Mao (Brest, France), L. Raj (Brest, Canada), C. Leroyer (Brest, France)

Source: Virtual Congress 2020 – Pulmonary embolism
Session: Pulmonary embolism
Session type: E-poster session
Number: 1860
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Couturaud (Brest, France), G. Picart (Brest, France), P. Robin (Brest, France), C. Tromeur (Brest, France), R. Le Mao (Brest, France), L. Raj (Brest, Canada), C. Leroyer (Brest, France). Predictors of Residual Pulmonary Vascular Obstruction after Pulmonary Embolism: results from a prospective cohort study. 1860

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The impact of Initial Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism: a French prospective cohort.
Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism
Year: 2020




Pulmonary arterial hypertension – A single-centre experience
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


Late Breaking Abstract - Balloon Pulmonary Angioplasty for the Treatment of Non Operable Chronic Thromboembolic Pulmonary Hypertension – Initial experience of a Belgian Center
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018



Poor Subpleural Perfusion as a predictor of Failure after Balloon Pulmonary Angioplasty for non-operable Chronic Thromboembolic Pulmonary Hypertension
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017


Pulmonary Embolism
Source: Breathe, 15 (4) 360; 10.1183/20734735.ELF154
Year: 2019



Clinical phenotypes in pulmonary emboli identified by cluster analysis
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014

Frequency and risk factors for Chronic Thromboembolic Pulmonary Hypertension after a first unprovoked Pulmonary Embolism: results from PADIS-studies.
Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension
Year: 2021



Long-term data from the Swiss pulmonary hypertension registry
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Outcomes in embolisations of pulmonary arterio-venous malformations
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014

Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study)
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

Quality of life of patients with pulmonary arterial hypertension associated with congenital heart disease: The multicenter cross-sectional ACHILLE study
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

Long-term screening for pulmonary hypertension after pulmonary embolism
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014


Prognosis factors of recurrent pulmonary thromboembolism
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014

Isolated hypocapnia: A sign not to be neglected
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014


Randomized, controlled, prospective multicenter study: Training improves peak oxygen consumption and hemodynamics in patients with chronic severe pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH
Year: 2014


Rivaroxaban for treatment of venous thromboembolism. A real-life perspective in 103 patients
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Alteration of factors associated with coagulation in provoked pulmonary embolism
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014

An overview of thrombolytic treatment for pulmonary embolism: A single center experience
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Exercise-induced pulmonary pressure changes in scleroderma patients – A follow-up study
Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange
Year: 2014